Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression.

Sorrentino ZA, Goodwin MS, Riffe CJ, Dhillon JS, Xia Y, Gorion KM, Vijayaraghavan N, McFarland KN, Golbe LI, Yachnis AT, Giasson BI.

Acta Neuropathol Commun. 2019 Sep 2;7(1):142. doi: 10.1186/s40478-019-0787-2.

2.

An anti-CRF antibody suppresses the HPA axis and reverses stress-induced phenotypes.

Futch HS, McFarland KN, Moore BD, Kuhn MZ, Giasson BI, Ladd TB, Scott KA, Shapiro MR, Nosacka RL, Goodwin MS, Ran Y, Cruz PE, Ryu DH, Croft CL, Levites Y, Janus C, Chakrabarty P, Judge AR, Brusko TM, de Kloet AD, Krause EG, Golde TE.

J Exp Med. 2019 Aug 29. pii: jem.20190430. doi: 10.1084/jem.20190430. [Epub ahead of print]

PMID:
31467037
3.

Intron retention induced by microsatellite expansions as a disease biomarker.

Sznajder ŁJ, Thomas JD, Carrell EM, Reid T, McFarland KN, Cleary JD, Oliveira R, Nutter CA, Bhatt K, Sobczak K, Ashizawa T, Thornton CA, Ranum LPW, Swanson MS.

Proc Natl Acad Sci U S A. 2018 Apr 17;115(16):4234-4239. doi: 10.1073/pnas.1716617115. Epub 2018 Apr 2.

4.

Correction to: SPG7 and Impaired Emotional Communication.

Zhang L, McFarland KN, Subramony SH, Heilman KM, Ashizawa T.

Cerebellum. 2017 Dec;16(5-6):991. doi: 10.1007/s12311-017-0901-6.

PMID:
29181771
5.

Parkinson's disease associated with pure ATXN10 repeat expansion.

Schüle B, McFarland KN, Lee K, Tsai YC, Nguyen KD, Sun C, Liu M, Byrne C, Gopi R, Huang N, Langston JW, Clark T, Gil FJJ, Ashizawa T.

NPJ Parkinsons Dis. 2017 Sep 5;3:27. doi: 10.1038/s41531-017-0029-x. eCollection 2017.

6.

Parkinson Disease and Autoimmune Disorders-What Can We Learn From Genome-wide Pleiotropy?

McFarland NR, McFarland KN, Golde TE.

JAMA Neurol. 2017 Jul 1;74(7):769-770. doi: 10.1001/jamaneurol.2017.0843. No abstract available.

PMID:
28586798
7.

Inheritance patterns of ATCCT repeat interruptions in spinocerebellar ataxia type 10 (SCA10) expansions.

Landrian I, McFarland KN, Liu J, Mulligan CJ, Rasmussen A, Ashizawa T.

PLoS One. 2017 Apr 19;12(4):e0175958. doi: 10.1371/journal.pone.0175958. eCollection 2017.

8.

SPG7 and Impaired Emotional Communication.

Zhang L, McFarland KN, Subramony SH, Heilman KM, Ashizawa T.

Cerebellum. 2017 Apr;16(2):595-598. doi: 10.1007/s12311-016-0818-5. Erratum in: Cerebellum. 2017 Nov 27;:.

9.

A case report of SPG11 mutations in a Chinese ARHSP-TCC family.

Zhang L, McFarland KN, Jiao J, Jiao Y.

BMC Neurol. 2016 Jun 3;16:87. doi: 10.1186/s12883-016-0604-5.

10.

Spinocerebellar ataxia type 10 in Chinese Han.

Wang K, McFarland KN, Liu J, Zeng D, Landrian I, Xia G, Hao Y, Jin M, Mulligan CJ, Gu W, Ashizawa T.

Neurol Genet. 2015 Oct 8;1(3):e26. doi: 10.1212/NXG.0000000000000026. eCollection 2015 Oct.

11.

SMRT Sequencing of Long Tandem Nucleotide Repeats in SCA10 Reveals Unique Insight of Repeat Expansion Structure.

McFarland KN, Liu J, Landrian I, Godiska R, Shanker S, Yu F, Farmerie WG, Ashizawa T.

PLoS One. 2015 Aug 21;10(8):e0135906. doi: 10.1371/journal.pone.0135906. eCollection 2015.

12.

ADAR2-dependent GluA2 editing regulates cocaine seeking.

Schmidt HD, McFarland KN, Darnell SB, Huizenga MN, Sangrey GR, Cha JH, Pierce RC, Sadri-Vakili G.

Mol Psychiatry. 2015 Nov;20(11):1460-6. doi: 10.1038/mp.2014.134. Epub 2014 Oct 28.

13.

Spinocerebellar ataxia type 10 in Peru: the missing link in the Amerindian origin of the disease.

Leonardi L, Marcotulli C, McFarland KN, Tessa A, DiFabio R, Santorelli FM, Pierelli F, Ashizawa T, Casali C.

J Neurol. 2014 Sep;261(9):1691-4. doi: 10.1007/s00415-014-7394-8. Epub 2014 Jun 17.

14.

Repeat interruptions in spinocerebellar ataxia type 10 expansions are strongly associated with epileptic seizures.

McFarland KN, Liu J, Landrian I, Zeng D, Raskin S, Moscovich M, Gatto EM, Ochoa A, Teive HA, Rasmussen A, Ashizawa T.

Neurogenetics. 2014 Mar;15(1):59-64. doi: 10.1007/s10048-013-0385-6. Epub 2013 Dec 7.

15.

Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias.

Matilla-Dueñas A, Ashizawa T, Brice A, Magri S, McFarland KN, Pandolfo M, Pulst SM, Riess O, Rubinsztein DC, Schmidt J, Schmidt T, Scoles DR, Stevanin G, Taroni F, Underwood BR, Sánchez I.

Cerebellum. 2014 Apr;13(2):269-302. doi: 10.1007/s12311-013-0539-y.

16.

Expansion of the Spinocerebellar ataxia type 10 (SCA10) repeat in a patient with Sioux Native American ancestry.

Bushara K, Bower M, Liu J, McFarland KN, Landrian I, Hutter D, Teive HA, Rasmussen A, Mulligan CJ, Ashizawa T.

PLoS One. 2013 Nov 20;8(11):e81342. doi: 10.1371/journal.pone.0081342. eCollection 2013.

17.

MeCP2: a novel Huntingtin interactor.

McFarland KN, Huizenga MN, Darnell SB, Sangrey GR, Berezovska O, Cha JH, Outeiro TF, Sadri-Vakili G.

Hum Mol Genet. 2014 Feb 15;23(4):1036-44. doi: 10.1093/hmg/ddt499. Epub 2013 Oct 8.

18.

Purkinje cell loss is the major brain pathology of spinocerebellar ataxia type 10.

Xia G, McFarland KN, Wang K, Sarkar PS, Yachnis AT, Ashizawa T.

J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1409-11. doi: 10.1136/jnnp-2013-305080. Epub 2013 Jun 29. No abstract available.

19.

Paradoxical effects of repeat interruptions on spinocerebellar ataxia type 10 expansions and repeat instability.

McFarland KN, Liu J, Landrian I, Gao R, Sarkar PS, Raskin S, Moscovich M, Gatto EM, Teive HA, Ochoa A, Rasmussen A, Ashizawa T.

Eur J Hum Genet. 2013 Nov;21(11):1272-6. doi: 10.1038/ejhg.2013.32. Epub 2013 Feb 27.

20.

Genome-wide increase in histone H2A ubiquitylation in a mouse model of Huntington's disease.

McFarland KN, Das S, Sun TT, Leyfer D, Kim MO, Xia E, Sangrey GR, Kuhn A, Luthi-Carter R, Clark TW, Sadri-Vakili G, Cha JH.

J Huntingtons Dis. 2013;2(3):263-77. doi: 10.3233/JHD-130066.

PMID:
25062675
21.

Transgenic models of spinocerebellar ataxia type 10: modeling a repeat expansion disorder.

McFarland KN, Ashizawa T.

Genes (Basel). 2012 Jul 30;3(3):481-91. doi: 10.3390/genes3030481. eCollection 2012 Sep. Review.

22.

Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease.

McFarland KN, Das S, Sun TT, Leyfer D, Xia E, Sangrey GR, Kuhn A, Luthi-Carter R, Clark TW, Sadri-Vakili G, Cha JH.

PLoS One. 2012;7(7):e41423. doi: 10.1371/journal.pone.0041423. Epub 2012 Jul 27.

23.

Molecular biology of Huntington's disease.

McFarland KN, Cha JH.

Handb Clin Neurol. 2011;100:25-81. doi: 10.1016/B978-0-444-52014-2.00003-3. Review.

PMID:
21496570
24.

Characterization of harpy/Rca1/emi1 mutants: patterning in the absence of cell division.

Riley BB, Sweet EM, Heck R, Evans A, McFarland KN, Warga RM, Kane DA.

Dev Dyn. 2010 Mar;239(3):828-43. doi: 10.1002/dvdy.22227.

25.

Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner.

Benn CL, Sun T, Sadri-Vakili G, McFarland KN, DiRocco DP, Yohrling GJ, Clark TW, Bouzou B, Cha JH.

J Neurosci. 2008 Oct 15;28(42):10720-33. doi: 10.1523/JNEUROSCI.2126-08.2008.

26.

Neural-specific inactivation of ShcA results in increased embryonic neural progenitor apoptosis and microencephaly.

McFarland KN, Wilkes SR, Koss SE, Ravichandran KS, Mandell JW.

J Neurosci. 2006 Jul 26;26(30):7885-97.

27.

Genetic locus half baked is necessary for morphogenesis of the ectoderm.

McFarland KN, Warga RM, Kane DA.

Dev Dyn. 2005 Jun;233(2):390-406.

28.

Mutations in half baked/E-cadherin block cell behaviors that are necessary for teleost epiboly.

Kane DA, McFarland KN, Warga RM.

Development. 2005 Mar;132(5):1105-16. Epub 2005 Feb 2.

29.

Correlation of urokinase activity from biopotency and high-performance liquid chromatographic assays.

Cox RA, McFarland KN, Sackett PH, Short MT.

J Chromatogr. 1986 Dec 24;370(3):495-500.

PMID:
3818823

Supplemental Content

Loading ...
Support Center